We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$32.7B
AUM Growth
+$312M
Cap. Flow
+$1.35B
Cap. Flow %
4.12%
Top 10 Hldgs %
18.31%
Holding
1,552
New
84
Increased
844
Reduced
551
Closed
70

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 13.34%
3 Healthcare 13.05%
4 Consumer Discretionary 9.86%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXNM
1351
TXNM Energy Inc
TXNM
$6.43B
$515K ﹤0.01%
11,538
+784
+7% +$35K
QTWO icon
1352
Q2 Holdings
QTWO
$3.71B
$514K ﹤0.01%
15,929
+748
+5% +$24.8K
DOC
1353
DELISTED
PHYSICIANS REALTY TRUST
DOC
$514K ﹤0.01%
42,192
-78,238
-65% -$1.08M
ENVA icon
1354
Enova International
ENVA
$6.2B
$511K ﹤0.01%
10,040
-1,678
-14% -$87.5K
SBCF icon
1355
Seacoast Banking Corp of Florida
SBCF
$3.27B
$509K ﹤0.01%
23,158
+4,285
+23% +$100K
SFM icon
1356
Sprouts Farmers Market
SFM
$7.31B
$508K ﹤0.01%
11,872
+367
+3% +$14.4K
OGN icon
1357
Organon & Co
OGN
$3.55B
$499K ﹤0.01%
28,780
-25,320
-47% -$528K
PRG icon
1358
PROG Holdings
PRG
$1.81B
$498K ﹤0.01%
14,981
+42
+0.3% +$1.46K
GFF icon
1359
Griffon
GFF
$4.29B
$493K ﹤0.01%
12,434
+1,916
+18% +$78.6K
RARE icon
1360
Ultragenyx Pharmaceutical
RARE
$2.56B
$492K ﹤0.01%
13,793
-1,957
-12% -$77.5K
GAP
1361
The Gap Inc
GAP
$7.28B
$492K ﹤0.01%
46,314
+2,174
+5% +$22.2K
USIG icon
1362
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$489K ﹤0.01%
10,178
-1,698
-14% -$83.5K
HAYW icon
1363
Hayward Holdings
HAYW
$3.28B
$482K ﹤0.01%
+34,177
New +$469K
HI
1364
DELISTED
Hillenbrand
HI
$478K ﹤0.01%
11,287
-3,746
-25% -$178K
CWT icon
1365
California Water Service
CWT
$3.14B
$477K ﹤0.01%
+10,092
New +$511K
STC icon
1366
Stewart Information Services
STC
$2.11B
$472K ﹤0.01%
10,766
+601
+6% +$27.2K
MMI icon
1367
Marcus & Millichap
MMI
$1.2B
$468K ﹤0.01%
15,967
+3,225
+25% +$108K
COHU icon
1368
Cohu
COHU
$2B
$466K ﹤0.01%
13,541
-1,158
-8% -$43.6K
KW
1369
DELISTED
Kennedy-Wilson Holdings
KW
$464K ﹤0.01%
31,497
+12,996
+70% +$210K
CLB icon
1370
Core Laboratories
CLB
$493M
$461K ﹤0.01%
19,193
-10,894
-36% -$267K
CRNC icon
1371
Cerence
CRNC
$368M
$460K ﹤0.01%
22,558
-1,086
-5% -$27.3K
SRC
1372
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$456K ﹤0.01%
13,603
-4,180
-24% -$161K
HEZU icon
1373
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$567M
$450K ﹤0.01%
14,644
+222
+2% +$7.01K
BWIN
1374
Baldwin Insurance Group
BWIN
$2.79B
$443K ﹤0.01%
19,062
+2,179
+13% +$54.5K
GEN icon
1375
Gen Digital
GEN
$16.6B
$441K ﹤0.01%
24,957
+10,069
+68% +$196K

Similar funds

Natixis Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Natixis Advisors held 1,552 positions worth $32.7B, up 0.96% from $32.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Natixis Advisors deployed $1.35B of net new capital in Q3 2023, opening 84 new positions and adding to 844 existing holdings. Its largest new stake was Kenvue: 1,823,834 shares worth $36.6M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $87.5M trimmed.

  • Natixis Advisors's largest Q3 2023 buy was Kenvue: 1,823,834 shares worth $36.6M.
  • Natixis Advisors added most to iShares Core MSCI EAFE ETF in Q3 2023, an estimated $140M increase.
  • Natixis Advisors's biggest Q3 2023 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $87.5M.
  • Natixis Advisors fully exited ABB Ltd in Q3 2023, selling an estimated $21.3M.
  • Natixis Advisors's ten largest holdings make up 18% of its $32.7B portfolio in Q3 2023.
  • Natixis Advisors opened 84 new positions and closed 70 in Q3 2023.
  • Natixis Advisors's portfolio value rose 0.96% quarter-over-quarter to $32.7B.

Based on Natixis Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.